Ubi-p63E promoter sequences drive expression of mys coding sequences carrying a predicted activating mutation in the transmembrane domain (carries the amino acid replacement L796R, which mimics talin-induced conformational changes by shortening the length of transmembrane domain that is buried in the plasma membrane).